Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

DCPH Stock Annual Income Statement. Download in Excel

Deciphera Pharmaceuticals Inc. logo

Deciphera Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

25.59
 
USD
  
0.00
  
(0.00%)
Previous close: 25.59  Open: 0.0  Bid:   Ask:
52 week range    
9.90   
   25.61
Mkt Cap: 2,213 M  Avg Vol (90 Days): 0
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 11th October 2024

Stock Rankings

45
Value
52
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

DCPH Income Statement

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-4.48-4.78-5.16-2.37-2.29
Basic EPS total-4.48-4.78-5.16-2.37-2.29
Basic weighted shares outstanding17 M35 M43 M56 M58 M76 M85 M
Cost of sales225000.03 M9 M4 M
Depreciation-150000.0-300000.0800000.02 M3 M3 M2 M
DepreciationAndAmortization-150000.0-300000.0800000.02 M3 M3 M2 M
DevelopmentExpense4 M
Diluted EPS total-2.99-2.82-4.48-4.78-5.16-2.37-2.29
Diluted normalized net income/share-2.37-2.29
Diluted weighted shares outstanding17 M35 M43 M56 M76 M85 M
GeneralAndAdministrativeExpense11 M21 M68 M114 M136 M120 M136 M
Gross operating profit25 M42 M93 M125 M160 M
Income before tax-50 M-100 M-192 M-266 M-300 M-178 M-195 M
Income restructuring and M&A-182000.0
Income taxes722000.0431000.0
Interest income5 M17 M
InterestExpenseNonOperating95000.084000.067000.0
MiscOtherSpecialCharges746000.04 M9 M5 M113000.05 M16 M
Net income from total operations-50 M-100 M-192 M-266 M-300 M-179 M-195 M
NetIncomeCommonStockholders-50 M-100 M-192 M-266 M-300 M-179 M-195 M
NetIncomeContinuousOperations-50 M-100 M-192 M-266 M-300 M-179 M-195 M
NetNonOperatingInterestIncomeExpense-95000.0-84000.0-67000.05 M17 M
Normalized income-154 M
Operating income-51 M-104 M-201 M-271 M-300 M-183 M-211 M
Operating income before depreciation (EBITDA)-50 M-99 M-195 M-269 M-297 M-180 M-209 M
OperatingExpense-51 M-104 M226 M313 M393 M308 M371 M
Other income net-746000.0-4 M-9 M-5 M-113000.0-5 M-16 M
OtherGandA11 M21 M68 M114 M136 M120 M136 M
OtherOperatingExpenses2 M-635000.0-1 M
RentAndLandingFees11 M21 M
Research & development expense40 M83 M158 M199 M257 M188 M234 M
ResearchExpense40 M83 M158 M199 M257 M188 M234 M
RestructringAndMnAIncome-182000.0
SalariesAndWages-5 M-10 M
Selling Gen & administrative expense11 M21 M68 M114 M136 M120 M136 M
Special income/charges182000.0
Total Income available for interest expense (EBIT)-50 M-100 M-192 M-271 M-300 M-183 M-211 M
Total common shares outstanding33 M38 M56 M58 M59 M76 M81 M
Total net income-50 M-100 M-192 M-266 M-300 M-179 M-195 M
Total ordinary shares86 M86 M86 M86 M86 M86 M86 M
Total revenues25 M42 M96 M134 M163 M
TotalExpenses-51 M-104 M226 M313 M396 M317 M374 M
TotalRevenue25 M42 M96 M134 M163 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University